📋 Tender Overview
Scope : To Build a Glucose Monitoring Systems Manufacturing Site in Ireland
U.S. medical device company Dexcom plans to invest 300 million euros ($330.8 million) over the next five years to build a manufacturing site in Ireland, creating up to 1,000 jobs.
The plans provide some good news for the Irish economy after announcements of job cuts at other foreign-owned companies.
Dexcom, which makes glucose monitoring systems for people with diabetes, would seek planning permission for land owned by the Irish government's investment agency (IDA) in Athenry.
This will be one of the biggest single private sector investments ever in the West of Ireland.
